CA2125494A1 - Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs - Google Patents

Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs

Info

Publication number
CA2125494A1
CA2125494A1 CA 2125494 CA2125494A CA2125494A1 CA 2125494 A1 CA2125494 A1 CA 2125494A1 CA 2125494 CA2125494 CA 2125494 CA 2125494 A CA2125494 A CA 2125494A CA 2125494 A1 CA2125494 A1 CA 2125494A1
Authority
CA
Canada
Prior art keywords
peptide
basic
amino acids
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2125494
Other languages
English (en)
Inventor
Barry Berkowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2125494A1 publication Critical patent/CA2125494A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA 2125494 1991-12-09 1992-12-03 Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs Abandoned CA2125494A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US803,629 1985-12-02
US80362991A 1991-12-09 1991-12-09

Publications (1)

Publication Number Publication Date
CA2125494A1 true CA2125494A1 (fr) 1993-06-24

Family

ID=25187054

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2125494 Abandoned CA2125494A1 (fr) 1991-12-09 1992-12-03 Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs

Country Status (5)

Country Link
EP (1) EP0661988A1 (fr)
JP (1) JPH07501820A (fr)
AU (1) AU3236293A (fr)
CA (1) CA2125494A1 (fr)
WO (1) WO1993011783A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
ES2316154T3 (es) 1995-08-23 2009-04-01 University Of British Columbia Peptidos cationicos antimicrobianos y procedimientos de seleccion de los mismos.
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6040293A (en) * 1996-11-06 2000-03-21 The Regents Of The University Of California Clavanins
US6010876A (en) * 1996-11-06 2000-01-04 The Regents Of The University Of California Clavanins
WO2005074968A2 (fr) * 2004-02-10 2005-08-18 Universiteit Maastricht Utilisation medicale de peptides basiques
GB0415985D0 (en) * 2004-07-19 2004-08-18 Taylor Russell Methods of manufacture and applications of a chelating compounds or substances that when used as a treatment for burns will assist in the growth
DK2252627T3 (en) 2008-01-24 2017-08-14 Esperance Pharmaceuticals MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME.
PL2627201T3 (pl) * 2010-10-12 2018-05-30 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Kompozycja zawierająca polipeptyd przeciwdrobnoustrojowy
PT105332A (pt) * 2010-10-12 2012-04-12 Cev Biotecnologia Das Plantas S A Agentes para utilização com antimicrobianos
WO2014070957A1 (fr) 2012-10-30 2014-05-08 Esperance Pharmaceuticals, Inc. Conjugués anticorps/médicament et leurs procédés d'utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
US5073542A (en) * 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus
CA2108455C (fr) * 1991-04-15 1999-01-19 Peter J. Edwards Compositions pharmaceutiques contre les troubles gastriques

Also Published As

Publication number Publication date
JPH07501820A (ja) 1995-02-23
AU3236293A (en) 1993-07-19
EP0661988A4 (fr) 1995-02-10
WO1993011783A1 (fr) 1993-06-24
EP0661988A1 (fr) 1995-07-12

Similar Documents

Publication Publication Date Title
US5221664A (en) Composition and treatment with biologically active peptides and toxic cations
AU674525B2 (en) Biologically active peptides having N-terminal substitutions
CA2125494A1 (fr) Traitement a l'aide d'une composition a base de peptides et d'agents de chelation biologiquement actifs
US5792831A (en) Analogues of magainin peptides containing D-amino acids
US5686563A (en) Biologically active peptides having n-terminal substitutions
US5217956A (en) Composition and treatment with biologically active peptides and certain anions
WO1991012015A1 (fr) Peptides amphiphiles biologiquement actifs et procede pour inhiber la croissance de cellules cibles, de virus ou de cellules contaminees par virus
CA2107674A1 (fr) Nouvelles compositions peptidiques et leur utilisation
US5208220A (en) Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
CA2150946A1 (fr) Traitement de tumeurs malignes de la peau a l'aide de peptides biologiquement actifs
EP0590044A4 (en) Composition and treatment with biologically active peptides having c-terminal substitutions
AU641129B2 (en) Composition and treatment with biologically active peptides and certain anions
AU693518B2 (en) Ion-channel forming amphiphilic peptides having n-terminal modifications
WO1991016066A1 (fr) Compositions et traitement a base de peptides biologiquement actifs et de cations toxiques
EP0533795A4 (en) Composition of and treatment with biologically active peptides having d-amino acid residues
WO1994019369A1 (fr) Traitement de tumeurs cancereuses au moyen d'inhibiteurs de protease et de peptides a activite biologique
WO1991016918A1 (fr) Composition et traitement utilisant des peptides biologiquement actifs ainsi que des agents parasiticides et des agents fongicides
WO1992000090A1 (fr) COMPOSITION ET TRAITEMENT A L'AIDE DE PEPTIDES BIOLOGIQUEMENT ACTIFS ET D'ANTIBIOTIQUES INHIBANT LA GYRASE d'ADN
WO1999003488A2 (fr) Peptides biologiquement actifs a toxicite reduite chez l'animal et procedes d'elaboration
CA2120337A1 (fr) Composition et traitement avec des peptides biologiquement actifs et antibiotique

Legal Events

Date Code Title Description
FZDE Dead